I am pleased to introduce Advances in Antibiotics & Antibodies is a peer-reviewed open access journal that publishes original research articles, review articles as well as case reports in a wide range of subjects. The journal's editorial board and table of contents are divided into a number of subject-specific domains, however articles published in the journal may appear in multiple domains.
Each article published by Advances in Antibiotics & Antibodies will be available on the journal's website in different formats; full-text HTML, downloadable full-text PDF, full-text ePUB, and format for Kindle device.ss
All published articles of this journal are included in the indexing and abstracting coverage of CAS Source Index (CASSI), Index Copernicus, Google Scholar, Sherpa Romeo, Academic Journals Database, GenamicsJournalSeek, JournalTOCs, CiteFactor, Electronic Journals Library, RefSeek, Hamdard University, EBSCO A-Z, Directory of Abstract Indexing for Journals, World Catalogue of Scientific Journals, OCLC- WorldCat, Scholarsteer, SWB online catalog, Virtual Library of Biology (vifabio), Publons, Dtufindit, Geneva Foundation for Medical Education and Research.
During the calendar year 2019, Advances in Antibiotics & Antibodies received a total of 30 papers, out of which 6 articles were rejected in the preliminary screening due to plagiarism or being out of the format and peer review process. During 2019 around 16 articles were subjected for publication after they are accepted in the peer review process. In the 4 issues of Volume 12 published during the year 2019, a total of 16 articles were published (at an average of 3 articles per issue of which, articles were published from authors all around the world. A total of 30 research scientists from all over the world reviewed the 16 articles published in volume 12. Average publication period of an article was further reduced to 14-21 days.
During the calendar year 2019, a total of three Editors, ten Reviewers joined the board of AAA and contributed their valuable services towards contribution as well as publication of articles, and their valuable reviewer comments will beneficial to publish quality of article in the Journal.
I take this opportunity to acknowledge the contribution of Editor-in-chief and Associate Editor during the final editing of articles published and bringing out issues of AAA in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, language editor, honorary editors, the scientific advisory and the editorial board of AAA, the office bearers for their support in bringing out the new volume (Volume 13) of AAA for the calendar year 2020 and look forward to their unrelenting support further to release more issues for Advances in Antibiotics & Antibodies AAA in scheduled time.